Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Pharma
Biokin, BMS' bispecific ADC hits goal in China lung cancer trial
With the positive readout in EGFR-mutated NSCLC, iza-bren poses another threat to TROP2-targeted ADCs.
Angus Liu
Aug 18, 2026 11:18am
Appeals court resurrects Celgene investor lawsuit against BMS
Aug 14, 2026 11:33am
BMS bags first FDA approval for CELMoD franchise with Zenbexus
Aug 14, 2026 10:09am
Of biopharma's top 25 companies, 9 had double-digit sales bumps
Aug 12, 2026 11:47am
BMS unveils $2.3B outlay for manufacturing campus in Houston
Aug 10, 2026 11:13am
‘No discussions’ ongoing for AstraZeneca-BMS merger: Reuters
Aug 5, 2026 10:12am
